"Long acting formulation" trang 1 - tải miễn phí từ tailieunhanh
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease

A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
8    31    1
Effect of meloxicam on pharmacokinetics of long acting moxifloxacin in goats

Effect of meloxicam on pharmacokinetics of long acting moxifloxacin in goats
5    88    0
Use of reproductive health services among women using long- or short-acting contraceptive methods – a register-based cohort study from Finland

Use of reproductive health services among women using long- or short-acting contraceptive methods – a register-based cohort study from Finland
12    17    1
Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism"
10    57    0
Use of long acting injectable aripiprazole before and through pregnancy in bipolar disorder: A case report

Use of long acting injectable aripiprazole before and through pregnancy in bipolar disorder: A case report
4    55    0
Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: A retrospective analysis

Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: A retrospective analysis
9    81    0
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
11    84    2
Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations: A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations: A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
8    40    1
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: A database study

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: A database study
9    40    1
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial

Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
10    30    1
Dose response of umeclidinium administered once or twice daily in patients with COPD: A randomised cross-over study

Dose response of umeclidinium administered once or twice daily in patients with COPD: A randomised cross-over study
14    22    1
A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: The GLOW5 study

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: The GLOW5 study
11    30    1
A cross-sectional study of the identification of prevalent asthma and chronic obstructive pulmonary disease among initiators of long-acting β-agonists in health insurance claims data

A cross-sectional study of the identification of prevalent asthma and chronic obstructive pulmonary disease among initiators of long-acting β-agonists in health insurance claims data
13    32    1
Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease
10    22    1
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study

A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study
10    24    1
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: A post hoc subgroup analysis

Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: A post hoc subgroup analysis
10    29    1
Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: A case-control study

Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: A case-control study
10    45    1
Results of asthma control with inhaled corticosteroid and long acting β2 adrenergic agonist in 3 months

Results of asthma control with inhaled corticosteroid and long acting β2 adrenergic agonist in 3 months
8    64    0
Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/ db and DIO mice

Potent long-acting rhFGF21 analog for treatment of diabetic nephropathy in db/ db and DIO mice
11    97    0
Inequalities in short-acting reversible, long-acting reversible and permanent contraception use among currently married women in India

Inequalities in short-acting reversible, long-acting reversible and permanent contraception use among currently married women in India
13    13    1